Article Text

Download PDFPDF

E-075 Outcomes of mechanical thrombectomy in anticoagulated patients with acute medium and distal vessel stroke
Free
  1. B Musmar1,
  2. N Adeeb2,
  3. H Salim3,
  4. S Ghozy4,
  5. NM Cancelliere5,
  6. V Mendes Pereira5,
  7. P Jabbour1,
  8. AA Dmytriw6,
  9. A Guenego7
  1. 1Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA
  2. 2Neurological Surgery, Louisiana State University, Shreveport, LA
  3. 3Radiology, Johns Hopkins University Hospital, Baltimore, MD
  4. 4Radiology, Mayo Clinic, Rochester, MN
  5. 5Neurovascular Centre, Divisions of Therapeutic Neuroradiology and Neurosurgery, St. Michael’s Hospit, Neurovascular Centre, Divisions of Therapeutic Neuroradiology and Neurosurgery, St. Michael’s Hospital, University of Toronto, ON, Canada., Toronto, ON, Canada
  6. 6Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Boston, MA
  7. 7Neuroradiology, Erasme University Hospital, Brussels, Belgium

Abstract

Background Stroke remains a major health concern globally, with oral anticoagulants widely prescribed for stroke prevention. The efficacy and safety of mechanical thrombectomy (MT) in anticoagulated patients with distal medium vessel occlusions (DMVO) are not well understood.

Methods This retrospective analysis involved 1,282 acute ischemic stroke (AIS) patients who underwent MT in 37 centers across North America, Asia, and Europe from September 2017 to July 2021. Data on demographics, clinical presentation, treatment specifics, and outcomes were collected. The primary outcomes were functional outcomes at 90 days post-MT, measured by modified Rankin Scale (mRS) scores. Secondary outcomes included reperfusion rates, mortality, and hemorrhagic complications.

Results Of the patients, 312 (24%) were on anticoagulation therapy. Anticoagulated patients were older (median age 72 vs. 64 years; p<0.0001) and had a higher prevalence of atrial fibrillation (73% vs. 24%; p<0.0001). Their baseline National Institutes of Health Stroke Scale (NIHSS) scores were also higher (median 12 vs. 10; p=0.012). Before PSM, anticoagulated patients had lower rates of favorable 90-day outcomes (mRS 0–1: 32% vs. 39%, p=0.033; mRS 0–2: 46% vs. 56%, p=0.0051) and higher mortality (26% vs. 14%, p<0.0001). After PSM, there were no significant differences in outcomes between the two groups.

Conclusion Anticoagulated patients undergoing MT for AIS due to DMVO did not show significant differences in 90-day mRS outcomes, reperfusion, or hemorrhage compared to non- anticoagulated patients after adjustment for covariates.

Disclosures B. Musmar: None. N. Adeeb: None. H. Salim: None. S. Ghozy: None. N. M Cancelliere: None. V. Mendes Pereira: None. P. Jabbour: None. A. A Dmytriw: None. A. Guenego: None.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.